Anticholinergic
An anticholinergic agent is a substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system. An example of an anticholinergic is dicyclomine. Generally speaking, it reduces the effects mediated by acetylcholine on acetylcholine receptors in neurons through competitive inhibition. The effect is therefore reversible.
Anticholinergics are classified according to the receptors that are affected:
- Antimuscarinic agents operate on the muscarinic acetylcholine receptors. The majority of anticholinergic drugs are antimuscarinics.
- Antinicotinic agents operate on the nicotinic acetylcholine receptors.
Effects
When a significant amount of an anticholinergic is taken into the body, a toxic reaction known as acute anticholinergic syndrome may result. This may happen accidentally or intentionally as a consequence of recreational drug use. Anticholinergic drugs are usually considered the least enjoyable by experienced recreational drug users, possibly due to the lack of euphoria caused by them. (For some of the recreational effects, see the article on deliriants.) Because most users do not enjoy the experience, they do not use it again, or do so very rarely. The risk of addiction is low in the anticholinergic class. The effects are usually more pronounced in the elderly, due to the decrease of acetylcholine production associated with age.
Possible effects of anticholinergics include:
- Ataxia; loss of coordination
- Decreased mucus production in the nose and throat; consequent dry, sore throat
- Xerostomia or dry mouth with possibly acceleration of caries
- Cessation of perspiration; consequent decreased thermal dissipation through the skin leading to hot, red skin
- Increased body temperature
- Pupil dilation (mydriasis); consequent sensitivity to bright light (photophobia)
- Loss of accommodation (loss of focusing ability, blurred vision — cycloplegia)
- Double vision (diplopia)
- Increased heart rate (tachycardia)
- Easily startled
- Urinary retention
- Diminished bowel movement, sometimes ileus
- Increased intraocular pressure, dangerous for people with narrow-angle glaucoma
- Shaking
Possible effects in the central nervous system resemble those associated with delirium, and may include:
- Confusion
- Disorientation
- Agitation
- Euphoria or dysphoria
- Respiratory depression
- Memory problems [1]
- Inability to concentrate
- Wandering thoughts; inability to sustain a train of thought
- Incoherent speech
- Wakeful myoclonic jerking
- Unusual sensitivity to sudden sounds
- Illogical thinking
- Photophobia
- Visual disturbances
- Periodic flashes of light
- Periodic changes in visual field
- Visual snow
- Restricted or "tunnel vision"
- Visual, auditory, or other sensory hallucinations[1]
- Warping or waving of surfaces and edges
- Textured surfaces
- "Dancing" lines; "spiders", insects
- Lifelike objects indistinguishable from reality
- Hallucinated presence of people not actually there
- Rarely: seizures, coma and death
Acute anticholinergic syndrome is completely reversible and subsides once all of the toxin has been excreted. Ordinarily, no specific treatment is indicated. However, in extreme cases, especially those that involves severe distortions of mental state, a reversible cholinergic agent such as physostigmine may be used.
Plant sources
The most common plants containing anticholinergic alkaloids are:
- Atropa belladonna (Deadly Nightshade)
- Brugmansia species (Brugmansia)
- Datura species (Datura)
- Hyoscamus niger (Henbane)
- Mandragora officinarum (Mandrake)
Use as a deterrent
Certain preparations of some drugs, such as Hydrocodone, are mixed with an anticholinergic agent to deter intentional overdose. [2]
References
Receptor agonists, antagonists, and reuptake inhibitors |
|
BA/M |
5-HT (serotonin) receptor
|
Serotonin receptor agonist (5-HT 4) · Serotonin antagonist (5-HT 3) · Serotonin uptake inhibitor ( SSRI)
|
|
|
Dopamine agonist · Dopamine antagonist · Dopamine reuptake inhibitor
|
|
|
Adrenergic agonist (Alpha, Beta 1/2) · Adrenergic antagonist (Alpha 1/2, Beta) · Adrenergic uptake inhibitor
|
|
Histamine receptor
|
Histamine agonist · Histamine antagonist ( H1, H2, H 3)
|
|
|
AA |
GABA receptor
|
GABA agonist · GABA antagonist
|
|
Glutamate receptor
|
NMDA receptor (NMDA receptor antagonist) · AMPA receptor (Ampakine) · Excitatory amino acid agonist · Excitatory amino acid antagonist
|
|
|
ANS |
Acetylcholine receptor
|
Cholinergic (Muscarinic, Nicotinic) · Anticholinergic (Muscarinic, Nicotinic/Ganglionic blocker/Neuromuscular-blocking drugs) · Acetylcholinesterase inhibitor
|
|
|
(SANS only—see above for details)
|
|
|
Parasympathomimetic (Cholinergic, Acetylcholinesterase inhibitor) · Parasympatholytic (Anticholinergic, Ganglionic blocker)
|
|
SANS
|
Sympathomimetic (Adrenergic agonist, Monoamine oxidase inhibitor) · Sympatholytic (Adrenergic antagonist, Alpha blocker, Ganglionic blocker)
|
|
|
Anticholinergics |
|
Nicotinic antagonists |
Ganglionic
|
nondepolarizing (Mecamylamine, Trimetaphan, Hexamethonium) · Nicotine (high doses)
note: in PNS, ganglionic blocker can have direct antinicotinic action at preganglionic terminal, but simulate indirect antimuscarinic activities at postganglionic terminal
|
|
Neuromuscular
|
Non-depolarising
|
Curare alkaloids
|
Alcuronium · Dimethyltubocurarine · Tubocurarine
|
|
4° ammonium
|
short duration: Mivacurium
intermediate: Atracurium/Cisatracurium · Fazadinium · Rocuronium (short onset) · Vecuronium
long: Doxacurium · Metocurine · Pancuronium · Pipecuronium
unsorted: Gallamine · Hexafluronium
|
|
|
Depolarising
|
|
|
|
|
Muscarinic antagonists |
nonpolar/tertiary/CNS: Atropine · Scopolamine · Hyoscyamine · antiparkinson drugs (Benzatropine, Trihexyphenidyl, Biperiden)
polar/quarternary/non-CNS: Glycopyrrolate · Ipratropium · M1 (Pirenzepine) · M3 (Tiotropium, Darifenacin, Vedaclidine)
unsorted: Tropicamide · Cyclopentolate · Dicycloverine · Tolterodine · Oxybutynin · Homatropine · Orphenadrine · Diphenhydramine · Other ethanolamine class first-generation antihistamines
|
|
Indirect |
acetylcholine synthesis inhibitor (Hemicholinium-3) · vesicle storage inhibitor (Vesamicol) · acetylcholine release inhibitor ( Botulinum toxin) · acetylcholine release stimulator (Alpha-latrotoxin) · acetylcholinesterase reactivators (Pralidoxime, Obidoxime)
|
|
Drugs for functional gastrointestinal disorders (A03) |
|
Drugs for
functional bowel disorders |
Antimuscarinics
|
Tertiary
amino group
|
Oxyphencyclimine · Camylofin · Mebeverine · Trimebutine · Rociverine · Dicycloverine · Dihexyverine · Difemerine · Piperidolate
|
|
Quaternary ammonium
compounds
|
Benzilone · Glycopyrronium · Oxyphenonium · Penthienate · Propantheline · Otilonium bromide · Methantheline · Tridihexethyl · Isopropamide · Hexocyclium · Poldine · Mepenzolate · Bevonium · Pipenzolate · Diphemanil · Tiemonium iodide · Prifinium bromide · Timepidium bromide · Fenpiverinium
|
|
|
Phosphodiesterase inhibitors
|
Papaverine · Drotaverine · Moxaverine
|
|
Acting on serotonin receptors
|
5-HT3 antagonists (Alosetron, Cilansetron) · 5-HT4 agonists (Mosapride, Tegaserod)
|
|
Other
|
Fenpiprane · Diisopromine · Chlorbenzoxamine · Pinaverium · Fenoverine · Idanpramine · Proxazole · Alverine · Trepibutone · Isometheptene · Caroverine · Phloroglucinol · Silicones · Trimethyldiphenylpropylamine
|
|
|
Belladonna and derivatives
(antimuscarinics) |
tertiary amines: Atropine · Hyoscyamine
quaternary ammonium compounds: Scopolamine (Butylscopolamine, Methylscopolamine) · Methylatropine · Fentonium · Cimetropium bromide
|
|
Propulsives |
primarily dopamine antagonists (Metoclopramide/Bromopride, Clebopride, Domperidone, Alizapride) · 5-HT4 agonists (Cisapride)
|
|
Urologicals (G04) |
|
Acidifiers |
|
|
Urinary antispasmodics
(primarily antimuscarinics) |
Darifenacin · Emepronium · Fesoterodine · Flavoxate · Imidafenacin · Meladrazine · Oxybutynin · Propiverine · Solifenacin · Terodiline · Tolterodine · Trospium
|
|
For erectile dysfunction |
|
Alprostadil
|
|
PDE5 inhibitors
|
Avanafil · Sildenafil · Tadalafil · Udenafil · Vardenafil
|
|
Alpha blockers
|
Moxisylyte · Phentolamine · Yohimbine
|
|
Others
|
Apomorphine · Papaverine
|
|
|
Other urologicals |
Acetohydroxamic acid · Collagen · Dimethyl sulfoxide · Magnesium hydroxide · Pentosan polysulfate · Phenazopyridine · Phenyl salicylate · Succinimide
|
|
For BPH |
5α-reductase inhibitors
|
Dutasteride · Finasteride
|
|
Alpha blockers (α1)
|
Alfuzosin · Doxazosin · Silodosin · Tamsulosin · Terazosin
|
|
|
Pygeum africanum · Serenoa repens
|
|
|
Skeletal Muscle relaxants (M03) |
|
Peripherally acting
(primarily antinicotinic,
NMJ blocking) |
Non-depolarising
|
Curare alkaloids
|
Alcuronium · Dimethyltubocurarine · Tubocurarine
|
|
4° ammonium
|
short duration: Mivacurium
intermediate: Atracurium/Cisatracurium · Fazadinium · Rocuronium (short onset) · Vecuronium
long: Doxacurium · Metocurine · Pancuronium · Pipecuronium
unsorted: Gallamine · Hexafluronium
|
|
|
Depolarising
|
|
|
|
|
|
|
Centrally acting |
Carbamic acid esters
|
Carisoprodol · Febarbamate · Meprobamate · Methocarbamol · Phenprobamate · Styramate · Tybamate
|
|
|
|
|
|
|
|
Other
|
Baclofen · Chlormezanone · Chlorphenesin • Chlorzoxazone · Donepezil · Mephenesin · Mephenoxalone · Metaxalone · Phenyramidol · Pridinol · Quinine · Thiocolchicoside · Tizanidine · Tolperisone
|
|
|
Directly acting |
Dantrolene
|
|
Anti-parkinson drugs: anticholinergic agents (primarily antimuscarinic) (N04A) |
|
Tertiary amines |
Trihexyphenidyl · Biperiden · Metixene · Procyclidine · Profenamine · Dexetimide · Phenglutarimide · Mazaticol · Bornaprine · Tropatepine
|
|
Ethers chemically close to antihistamines |
Etanautine · Orphenadrine
|
|
Ethers of tropine or tropine derivatives |
Benztropine · Etybenzatropine
|
|
Drugs for obstructive airway diseases: asthma/COPD (R03) |
|
Adrenergics, inhalants |
Short acting β2-agonists
|
Salbutamol/Levosalbutamol • Fenoterol • Terbutaline • Pirbuterol • Procaterol • Bitolterol • Rimiterol • Carbuterol • Tulobuterol • Reproterol
|
|
Long acting β2-agonists (LABA)
|
Arformoterol • Bambuterol • Clenbuterol • Formoterol • Salmeterol Ultra LABA: Indacaterol
|
|
other
|
Epinephrine • Hexoprenaline • Isoprenaline (Isoproterenol) • Orciprenaline (Metaproterenol)
|
|
|
Glucocorticoids |
Beclometasone • Budesonide • Ciclesonide • Fluticasone • Mometasone
|
|
Anticholinergics/
muscarinic antagonist |
Ipratropium • Tiotropium
|
|
Mast cell stabilizers |
Cromoglicate • Nedocromil
|
|
Xanthines |
|
|
Eicosanoid inhibition |
Leukotriene antagonists
|
Montelukast • Pranlukast • Zafirlukast
|
|
Lipoxygenase inhibitor
|
Zileuton
|
|
Thromboxane receptor antagonists
|
Ramatroban • Seratrodast
|
|
|
Combination products |
Budesonide/formoterol • Fluticasone/salmeterol • Ipratropium/salbutamol
|
|
Ophthalmologicals: mydriatics and cycloplegics (S01F) |
|
Anticholinergics/antimuscarinics |
Atropine - Scopolamine - Methylscopolamine - Cyclopentolate - Homatropine - Tropicamide
|
|
Sympathomimetics |
|
|